Allergy Immunotherapy Market to Reach USD 3.43 Billion by 2030, Driven By Rising Demand for Injection-Free Treatments

Mordor Intelligence has published a new report on the Allergy Immunotherapy Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The global allergy immunotherapy market, currently valued at USD 2.50 billion in 2025, is projected to expand to USD 3.43 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.56% between 2025 and 2030.

This upward trend is largely driven by the increasing prevalence of respiratory and food allergies, ongoing regulatory approvals of new biologics, and a growing patient preference for non-invasive treatment formats. The market's medium concentration reflects a competitive landscape featuring both established players and emerging innovators.

Report Overview: https://www.mordorintelligence.com/industry-reports/allergy-immunotherapy-market?utm_source=openpr

Key Market Trends

1. Growing Preference for Non-Invasive Therapies

There is increasing adoption of epicutaneous (EPIT) and sublingual (SLIT) immunotherapies over traditional subcutaneous immunotherapy (SCIT).

EPIT, particularly in the form of skin patches, is expected to grow at a CAGR of 14.25% through 2030 due to higher patient compliance and ease of use.

2. Expansion of Food Allergy Treatments

The market is witnessing strong growth in treatments targeting food allergies, driven by rising prevalence and recent regulatory approvals.

Notably, FDA approval of Xolair (omalizumab) for multiple food allergens in early 2024 has set the stage for further growth in this application.

3. Increase in Biologics and Biosimilar Launches

Biologic therapies are playing a larger role, particularly for asthma and food allergy treatment.

The launch of omalizumab biosimilars in 2025 is expected to increase accessibility and competition in the market.

4. Rising Use of Patient-Centric Delivery Formats

Patients are shifting away from injectable suspensions (which still made up 55.6% of the market in 2024) toward oral tablets and transdermal patches.

These formats support better adherence, especially in pediatric and elderly populations.

Market Segmentation

By Immunotherapy Type

Subcutaneous Immunotherapy (SCIT)

Sublingual Immunotherapy (SLIT) - Drops

Sublingual Immunotherapy (SLIT) - Tablets

Epicutaneous Immunotherapy (EPIT)

Oral Immunotherapy (OIT)

By Allergy Type

Allergic Rhinitis

Allergic Asthma

Food Allergy

Venom Allergy

Atopic Dermatitis

Others

By Formulation

Injectable Suspensions

Sublingual Drops

Sublingual Tablets

Transdermal Patches

By Distribution Channel

Direct to-Physician Sales

Retail & Hospital Pharmacies

E-commerce / Mail-Order

By Geography

North America

Europe

Asia Pacific

Middle East and Africa

South America

Explore Our Full Library of Healthcare Industry Research Reports

https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr

Key Players

1. ALK‐Abelló A/S

A Danish pharmaceutical company founded in 1923, ALK‐Abelló is one of the world's largest manufacturers of allergy immunotherapy products. They produce a comprehensive range of treatments subcutaneous injections, sublingual tablets, and drops for common environmental allergens. The company places strong emphasis on standardized allergen extract production and operates globally, with major facilities and a long history of innovation in AIT

2. Stallergenes Greer

Stallergenes Greer is a Swiss-headquartered biopharmaceutical company formed by the 2015 merger of France's Stallergenes and the USA's Greer Laboratories. It specializes in diagnostic and therapeutic solutions for allergies, offering both subcutaneous and sublingual immunotherapy products under brands like Oralair®, Actair®, and Alustal®. The company manages global operations across 44 countries and is advancing personalized delivery devices to improve patient adherence.

3. Allergy Therapeutics plc

Headquartered in the UK, Allergy Therapeutics plc focuses on developing both subcutaneous (SCIT) and sublingual (SLIT) vaccines. According to Mordor Intelligence, they are among the top five players in this field. Additionally, they are developing nanoparticle-based peanut allergy treatments, with early-stage trials showing promising reductions in skin sensitivity.

4. HAL Allergy Group

HAL Allergy is a Netherlands-based company, established in 1959, specializing in allergen extract development and immunotherapy for respiratory allergies, venom, and food allergies. They focus on both SCIT and SLIT products (e.g., SUBLIVAC, PURETHAL, VENOMENHAL) and offer contract manufacturing for biopharmaceuticals via their HALIX arm. HAL maintains a strong position in Europe's allergy treatment landscape

5. Torii Pharmaceutical Co., Ltd.

A Japanese pharmaceutical firm, Torii Pharmaceutical collaborates with global allergy leaders (such as ALK) to develop and commercialize SLIT and SCIT products specifically for the Japanese market. While Mordor recognizes them as a key market player, specific product references are more limited in public reports

Get More information on Allergy Immunotherapy Market Key Players: https://www.mordorintelligence.com/industry-reports/allergy-immunotherapy-market/companies?utm_source=openpr

Conclusion

The allergy immunotherapy market is poised for steady growth, with its value expected to rise from USD 2.50 billion in 2025 to USD 3.43 billion by 2030, supported by a growing patient population affected by allergic conditions such as asthma, rhinitis, and food allergies. This expansion is underpinned by rising demand for non-invasive treatment formats, increasing availability of biologics and biosimilars, and ongoing approvals of therapies for food allergies.

Industry Related Reports

Allergy Treatment Market: The Allergy Treatment Market report is segmented by Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergy, and Other Allergies), by Treatment (Anti-Allergy Drugs and Immunotherapy), and by Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).

Get More Insights: https://www.mordorintelligence.com/industry-reports/allergy-treatment-market?utm_source=openpr

Allergy Diagnostics Market: The Allergy Diagnostics Market report is segmented by Allergen Type (Inhaled Allergens, Food Allergens, and Other Allergens), by Product (Instruments, Consumables, and Luminometers), by End-User (Diagnostic Laboratories, Hospitals, and Other End-Users), and by Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).

Get More Insights: https://www.mordorintelligence.com/industry-reports/allergy-diagnostics-market?utm_source=openpr

Allergy Immunotherapy Market: The Allergy Immunotherapy Market report is segmented by Immunotherapy Type (Subcutaneous Immunotherapy and Sublingual Immunotherapy, including Drops and others), by Allergy Type (Allergic Rhinitis, Allergic Asthma, and others), by Formulation (Injectable Suspensions and others), by Distribution Channel (Direct-to-Physician Sales and others), and by Geography (North America, Europe, and others).

Get More Insights: https://www.mordorintelligence.com/industry-reports/allergy-immunotherapy-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.